Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yulia Nefedova

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Cancer Biology & Therapy|July 16, 2015
Efficacy of the HSP70 inhibitor PET-16 in multiple myelomaCharvann K Bailey, Anna Budina-Kolomets, Maureen E Murphy, et al.
Blood|August 9, 2003
Notch signaling is necessary but not sufficient for differentiation of dendritic cellsPingyan Cheng, Yulia Nefedova, Lucio Miele, et al.
Blood|December 13, 2003
Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell linesYulia Nefedova, Pingyan Cheng, Melissa Alsina, et al.
Cancer Biology & Therapy|March 3, 2016
Anti-myeloma effect of pharmacological inhibition of Notch/gamma-secretase with RO4929097 is mediated by modulation of tumor microenvironmentAlexandra Pisklakova, Eileen Grigson, Maria Ozerova, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 4, 2011
Gamma-secretase inhibitor enhances the cytotoxic effect of bortezomib in multiple myelomaFeng Chen, Alexandra Pisklakova, Ming Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2013
Regulation of dendritic cell differentiation in bone marrow during emergency myelopoiesisHao Liu, Jie Zhou, Pingyan Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancerBin Yu, Sergei Kusmartsev, Fengdong Cheng, et al.
Cancer Research|August 9, 2003
All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccinationSergei Kusmartsev, Fengdong Cheng, Bin Yu, et al.
Cancer Research|November 17, 2007
Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cellsYulia Nefedova, Mayer Fishman, Simon Sherman, et al.
Blood|November 28, 2007
Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapyYulia Nefedova, Daniel M Sullivan, Sophia C Bolick, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Cancer Biology & Therapy|July 16, 2015
Efficacy of the HSP70 inhibitor PET-16 in multiple myelomaCharvann K Bailey, Anna Budina-Kolomets, Maureen E Murphy, et al.
Blood|August 9, 2003
Notch signaling is necessary but not sufficient for differentiation of dendritic cellsPingyan Cheng, Yulia Nefedova, Lucio Miele, et al.
Blood|December 13, 2003
Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell linesYulia Nefedova, Pingyan Cheng, Melissa Alsina, et al.
Cancer Biology & Therapy|March 3, 2016
Anti-myeloma effect of pharmacological inhibition of Notch/gamma-secretase with RO4929097 is mediated by modulation of tumor microenvironmentAlexandra Pisklakova, Eileen Grigson, Maria Ozerova, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 4, 2011
Gamma-secretase inhibitor enhances the cytotoxic effect of bortezomib in multiple myelomaFeng Chen, Alexandra Pisklakova, Ming Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2013
Regulation of dendritic cell differentiation in bone marrow during emergency myelopoiesisHao Liu, Jie Zhou, Pingyan Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancerBin Yu, Sergei Kusmartsev, Fengdong Cheng, et al.
Cancer Research|August 9, 2003
All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccinationSergei Kusmartsev, Fengdong Cheng, Bin Yu, et al.
Cancer Research|November 17, 2007
Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cellsYulia Nefedova, Mayer Fishman, Simon Sherman, et al.
Blood|November 28, 2007
Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapyYulia Nefedova, Daniel M Sullivan, Sophia C Bolick, et al.
Pageof 6